









Markets
/
Stocks
/
nasdaq-anro
/

Alto Neuroscience Inc

ANRO

3.600USD

-0.455-11.07%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

97.46MMarket Cap

LossP/E TTM



Alto Neuroscience Inc

3.600

-0.455-11.07%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-17.83%-13.78M

-50.74%-16.56M

-12.99%-13.02M

-51.01%-11.73M

-76.25%-11.69M

-45.97%-10.98M

-91.40%-11.52M

---7.76M

---6.63M

---7.52M

---6.02M

Net income from continuing operations

-10.46%-17.71M

-13.06%-15.17M

-35.52%-15.20M

-83.60%-16.78M

-85.04%-16.03M

-84.20%-13.42M

-46.59%-11.22M

---9.14M

---8.66M

---7.28M

---7.65M

Operating gains losses

49.56%169.00K

76.29%171.00K

84.78%170.00K

46.99%122.00K

0.89%113.00K

12.79%97.00K

-5.15%92.00K

--83.00K

--112.00K

--86.00K

--97.00K

Other non-cash items

-75.67%192.00K

1109.72%871.00K

197.18%211.00K

-100.00%0.00

1043.48%789.00K

-4.00%72.00K

77.50%71.00K

--65.00K

--69.00K

--75.00K

--40.00K

Change in working capital

-9.44%1.29M

-1727.06%-4.66M

108.56%99.00K

234.05%2.79M

138.33%1.43M

73.87%-255.00K

-241.32%-1.16M

--834.00K

--600.00K

---976.00K

--818.00K

-Change in receivables

----

---8.00K

-100.00%0.00

121.62%8.00K

-100.00%0.00

--295.00K

--67.00K

---37.00K

--1.02M

-Change in prepaid expenses

310.48%509.00K

5.42%-1.69M

266.40%458.00K

1007.32%744.00K

-67.96%124.00K

-285.56%-1.79M

144.17%125.00K

---82.00K

--387.00K

---464.00K

---283.00K

Cash from non-recurring investing activities

Cash from operating activities

-17.83%-13.78M

-50.74%-16.56M

-12.99%-13.02M

-51.01%-11.73M

-76.25%-11.69M

-45.97%-10.98M

-91.40%-11.52M

---7.76M

---6.63M

---7.52M

---6.02M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

-89.29%24.00K

43.75%506.00K

2237.21%1.00M

529.63%340.00K

966.67%224.00K

467.74%352.00K

--43.00K

--54.00K

--21.00K

--62.00K

Capital expenditures

-100.00%0.00

-89.29%24.00K

43.75%506.00K

2237.21%1.00M

529.63%340.00K

966.67%224.00K

467.74%352.00K

--43.00K

--54.00K

--21.00K

--62.00K

Net cash flow from disposal of fixed assets

-100.00%0.00

-89.29%24.00K

43.75%506.00K

2237.21%1.00M

529.63%340.00K

966.67%224.00K

467.74%352.00K

--43.00K

--54.00K

--21.00K

--62.00K

Cash from non-current investing activities

Net cash flow from investing activities

100.00%0.00

89.29%-24.00K

-43.75%-506.00K

-2237.21%-1.00M

-529.63%-340.00K

-966.67%-224.00K

-467.74%-352.00K

---43.00K

---54.00K

---21.00K

---62.00K

Financing cash flow

Cash flow from continuous financing activities

361.97%613.00K

-93.22%9.13M

-99.89%49.00K

2587.76%1.32M

-358.82%-234.00K

438.24%134.56M

118.81%43.13M

--49.00K

---51.00K

--25.00M

--19.71M

Net cash flow from debt Issuance/repayment

--750.00K

--9.47M

--0.00

--1.25M

----

--9.82M

Net cash flow from common stock issuance/repurchase

--0.00

-100.00%0.00

--0.00

--137.58M

625.00%29.00K

--152.00K

--0.00

--4.00K

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

--0.00

-100.00%0.00

348.21%45.00M

--0.00

--25.00M

--10.04M

Proceeds from stock option exercised by employees

-100.00%0.00

1880.00%198.00K

--49.00K

255.81%67.00K

41.86%61.00K

--10.00K

----

---43.00K

--43.00K

--0.00

----

Net cash flow from other financing activities

53.56%-137.00K

81.98%-546.00K

100.00%0.00

-213.83%-295.00K

---3.03M

-1108.28%-1.90M

---60.00K

---94.00K

--0.00

---157.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

361.97%613.00K

-93.22%9.13M

-99.89%49.00K

2587.76%1.32M

-358.82%-234.00K

438.24%134.56M

118.81%43.13M

--49.00K

---51.00K

--25.00M

--19.71M

Net cash flow

Beginning cash balance

-21.68%161.25M

104.40%168.73M

255.25%182.20M

228.01%193.62M

213.01%205.90M

70.75%82.55M

47.83%51.29M

--59.03M

--65.78M

--48.34M

--34.70M

Current period cash flow changes

-7.30%-13.17M

-106.06%-7.47M

-143.10%-13.47M

-47.54%-11.42M

-81.80%-12.27M

607.43%123.35M

129.03%31.26M

---7.74M

---6.75M

--17.44M

--13.65M

Effect of exchange rate changes

40.00%-3.00K

-340.00%-22.00K

50.00%6.00K

-138.89%-7.00K

54.55%-5.00K

73.68%-5.00K

-80.00%4.00K

--18.00K

---11.00K

---19.00K

--20.00K

Ending cash balance

-23.52%148.09M

-21.68%161.25M

104.40%168.73M

255.25%182.20M

228.01%193.62M

213.01%205.90M

70.75%82.55M

--51.29M

--59.03M

--65.78M

--48.34M

Free cash flow

-14.50%-13.78M

-47.94%-16.58M

-13.90%-13.53M

-63.05%-12.73M

-79.91%-12.03M

-48.54%-11.21M

-95.23%-11.88M

---7.81M

---6.69M

---7.54M

---6.08M

Currency unit

USD

Audit opinions

KeyAI

